3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
HIV Infections
1
Carcinoma, Renal Cell
1
Burkitt Lymphoma
1
Interventions
Rituximab
165
Cyclophosphamide
163
fludarabine phosphate
95
Peripheral Blood Stem Cell Transplantation
88
Filgrastim
72
Etoposide
65
Mycophenolic Acid
63
Whole-Body Irradiation
62
Cytarabine
59
Cyclosporine
53
Melphalan
52
Tacrolimus
47
Busulfan
43
Radiotherapy
42
Lenalidomide
42
Bortezomib
40
ibrutinib
39
fludarabine
39
Methotrexate
38
Antilymphocyte Serum
38
Carmustine
37
Bendamustine Hydrochloride
35
Vincristine
33
Doxorubicin
32
Dexamethasone
32
Granulocyte Colony-Stimulating Factor
29
Prednisone
26
Cord Blood Stem Cell Transplantation
25
venetoclax
22
obinutuzumab
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, Mantle-Cell
×
Transplantation Conditioning
×
Clear all
NCT00946374
2009-07-27
HD-MCL2003
Heidelberg University
Phase 2
Unknown
20 enrolled